Impact of an Open Access Nationwide Treatment Model on Hepatitis C Virus Antiviral Drug Resistance

Direct acting antivirals (DAAs) have revolutionized hepatitis C virus (HCV) treatment, but drug resistance could undermine proposed global elimination targets. Real‐world studies are needed to inform the impact of widespread DAA treatment on antiviral resistance in the community. The prevalence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Douglas, Mark W., Tay, Enoch S.E., Wang, Dao Sen, Ong, Adrian T.L., Wilson, Caroline, Phu, Amy, Kok, Jen, Dwyer, Dominic E., Bull, Rowena A., Lloyd, Andrew R., Applegate, Tanya L., Dore, Gregory J., Howe, Anita Y., Harrigan, Richard, George, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262285/
https://www.ncbi.nlm.nih.gov/pubmed/32490325
http://dx.doi.org/10.1002/hep4.1496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262285/
https://www.ncbi.nlm.nih.gov/pubmed/32490325
http://dx.doi.org/10.1002/hep4.1496

Ejemplares similares